Premature Ejaculation - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Price : Single User: US $ 2950  US $ 2360 Corporate User: US $ 8850  US $ 5310
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Premature Ejaculation -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Premature Ejaculation in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Premature Ejaculation. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Premature Ejaculation. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Premature Ejaculation sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Premature Ejaculation market.

  • Identifying prevalent patient populations as well as risk factors in the global Premature Ejaculation market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Premature Ejaculation therapeutics in each of the markets covered.

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Premature Ejaculation - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Premature Ejaculation Overview
Premature Ejaculation Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Premature Ejaculation

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Premature Ejaculation
Sex-Specific Prevalent/Incident Cases of Premature Ejaculation
Disease Type Specific Prevalent/Incident Cases of Premature Ejaculation

8.Prevalent & Incident Cases by 7 MM-2015-2025
Premature Ejaculation Epidemiology of United States-2025
Premature Ejaculation Epidemiology of United Kingdom-2025
Premature Ejaculation Epidemiology of Germany-2025
Premature Ejaculation Epidemiology of France-2025
Premature Ejaculation Epidemiology of Spain-2025
Premature Ejaculation Epidemiology of Italy-2025
Premature Ejaculation Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Premature Ejaculation Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Premature Ejaculation (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Premature Ejaculation Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Premature Ejaculation (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Premature Ejaculation Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Premature Ejaculation (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Premature Ejaculation Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Premature Ejaculation (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Premature Ejaculation Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Premature Ejaculation (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Premature Ejaculation Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Premature Ejaculation (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Premature Ejaculation Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Premature Ejaculation (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Premature Ejaculation Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Premature Ejaculation Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Premature Ejaculation (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Premature Ejaculation Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Premature Ejaculation (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Premature Ejaculation Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Premature Ejaculation (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Premature Ejaculation Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Premature Ejaculation (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Premature Ejaculation Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Premature Ejaculation (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Premature Ejaculation Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Premature Ejaculation (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Premature Ejaculation Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Premature Ejaculation (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Premature Ejaculation By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Premature Ejaculation Sub-population,Japan (2015-2025)
  • Global and Regional Overactive Bladder Treatment Market Research Report 2017
    Published: 06-Dec-2017        Price: US 3500 Onwards        Pages: 144
    Summary Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Anticholinergics - Mirabegr......
  • Global Overactive Bladder Treatment Market Data Survey Report 2025
    Published: 29-Nov-2017        Price: US 1500 Onwards        Pages: 87
    Summary Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). The global Overactive Bladder Treatment market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market s......
  • Global and China Overactive Bladder Treatment Market Research by Company, Type & Application 2013-2025
    Published: 24-Nov-2017        Price: US 2000 Onwards        Pages: 93
    Summary Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). Market Segment as follows: By Type - Anticholinergics - Mirabegron - Botox By Application - Idiopathic Overactive Bladder - Neurogenic Overactive Bladder......
  • Global Overactive Bladder Treatment Market Research Report 2011-2023
    Published: 21-Nov-2017        Price: US 1800 Onwards        Pages: 86
    Summary Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). The global Overactive Bladder Treatment market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to d......
  • Global Overactive Bladder Treatment Market Research Report 2017
    Published: 09-Nov-2017        Price: US 2900 Onwards        Pages: 115
    This report studies Overactive Bladder Treatment in Global market, especially in North America, Europe, China, Japan, focuses on top manufacturers in global market, with revenue and market share for each manufacturer, covering Astellas Pharma Allergan Pfizer Teva (Activas) Johnson & Johnson Market Segment by Regions, this report splits Global into several key Regions, with consumption, revenue, market share and growth rate of Overactive Bladder T......
  • Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Cystitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Cystitis which can turn out to be future prospe......
  • Nocturnal Enuresis -Epidemiology Forecast to 2025
    Published: 01-Nov-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Nocturnal Enuresis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Nocturnal Enuresis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Nocturnal Enuresis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with......
  • Urinary Incontinence - Market Insights, Epidemiology and Market Forecast -2023-7MM
    Published: 01-Nov-2017        Price: US 4950 Onwards        Pages: 77
    DelveInsight's "Urinary Incontinence - Market Insights, Epidemiology and Market Forecast-2023-7MM" Reports provides an overview of the disease and global market size of the Urinary Incontinence for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Urinary Incontinence from 2013-2023. Urinary Incontinence is a multifactorial syndrome which occurs due to the failure of the storage ......
  • Interstitial Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Interstitial Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Interstitial Cystitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Interstitial Cystitis......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs